PAR 5.00% 19.0¢ paradigm biopharmaceuticals limited..

Ann: Paradigm Appoints Experienced US-Based CEO, page-39

  1. 5,195 Posts.
    lightbulb Created with Sketch. 671
    So bcos he said a goal of his was to grow shareholder value, that means it will happen?? I said it looks to b a great appointment.. What else do u want people to say?? If this was ‘guaranteed’ the sp wouldn’t b where it is.. 65% of ph3 drugs get approved which means that 35% dont. Ph3 doesn’t guarantee anything
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.